Surrogate to predict overall survival in patients with BRAF V600E-mutant colorectal cancer treated with BRAF inhibitor combinations by J. Ros, V. Navarro, G. Villacampa, I. Baraibar, F. Salvà, M. Rodriguez, C. Vaghi, A. Garcia, A. Alcaraz, J. Tabernero, E. Élez, R. Dienstmann

Get full text

Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers by J. Palomero, V. Galvao, I. Creus, J. Lostes, M. Aylagas, A. Marín-Bayo, M. Rotxés, M. Sanz, M. Lozano-Rabella, A. Garcia-Garijo, A. Yuste-Estevanez, D. Grases, J. Díaz-Gómez, J. González, J.F. Navarro, J.J. Gartner, I. Braña, X. Villalobos, N. Bayó-Puxan, J. Jiménez, A.N. Palazón, S. Muñoz, G. Villacampa, A. Piris-Giménez, P. Barba, M. Codinach, L. Rodríguez, S. Querol, E. Muñoz-Couselo, J. Tabernero, S. Martín-Lluesma, A. Gros, E. Garralda

Get full text